Cargando…

Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment

Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe the successful treatment of CAA encephalopathy with dexamethasone in a patient with CAA-related inflammation causing subacute progressive enceph...

Descripción completa

Detalles Bibliográficos
Autores principales: Kloppenborg, Raoul P, Richard, Edo, Sprengers, Marieke ES, Troost, Dirk, Eikelenboom, Piet, Nederkoorn, Paul J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846904/
https://www.ncbi.nlm.nih.gov/pubmed/20214781
http://dx.doi.org/10.1186/1742-2094-7-18
_version_ 1782179515837972480
author Kloppenborg, Raoul P
Richard, Edo
Sprengers, Marieke ES
Troost, Dirk
Eikelenboom, Piet
Nederkoorn, Paul J
author_facet Kloppenborg, Raoul P
Richard, Edo
Sprengers, Marieke ES
Troost, Dirk
Eikelenboom, Piet
Nederkoorn, Paul J
author_sort Kloppenborg, Raoul P
collection PubMed
description Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe the successful treatment of CAA encephalopathy with dexamethasone in a patient with CAA-related inflammation causing subacute progressive encephalopathy and seizures, which is an increasingly recognized subtype of CAA. The two pathological subtypes of CAA-related inflammation are described and a review of the literature is performed concerning immunosuppressive treatment of CAA-related inflammation with special attention to its pathological subtypes. Immunosuppressive therapy appears to be an appropriate treatment for CAA encephalopathy.
format Text
id pubmed-2846904
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28469042010-03-30 Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment Kloppenborg, Raoul P Richard, Edo Sprengers, Marieke ES Troost, Dirk Eikelenboom, Piet Nederkoorn, Paul J J Neuroinflammation Case report Cerebral amyloid angiopathy (CAA) is a common but often asymptomatic disease, characterized by deposition of amyloid in cerebral blood vessels. We describe the successful treatment of CAA encephalopathy with dexamethasone in a patient with CAA-related inflammation causing subacute progressive encephalopathy and seizures, which is an increasingly recognized subtype of CAA. The two pathological subtypes of CAA-related inflammation are described and a review of the literature is performed concerning immunosuppressive treatment of CAA-related inflammation with special attention to its pathological subtypes. Immunosuppressive therapy appears to be an appropriate treatment for CAA encephalopathy. BioMed Central 2010-03-09 /pmc/articles/PMC2846904/ /pubmed/20214781 http://dx.doi.org/10.1186/1742-2094-7-18 Text en Copyright ©2010 Kloppenborg et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case report
Kloppenborg, Raoul P
Richard, Edo
Sprengers, Marieke ES
Troost, Dirk
Eikelenboom, Piet
Nederkoorn, Paul J
Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
title Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
title_full Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
title_fullStr Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
title_full_unstemmed Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
title_short Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
title_sort steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment
topic Case report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846904/
https://www.ncbi.nlm.nih.gov/pubmed/20214781
http://dx.doi.org/10.1186/1742-2094-7-18
work_keys_str_mv AT kloppenborgraoulp steroidresponsiveencephalopathyincerebralamyloidangiopathyacasereportandreviewofevidenceforimmunosuppressivetreatment
AT richardedo steroidresponsiveencephalopathyincerebralamyloidangiopathyacasereportandreviewofevidenceforimmunosuppressivetreatment
AT sprengersmariekees steroidresponsiveencephalopathyincerebralamyloidangiopathyacasereportandreviewofevidenceforimmunosuppressivetreatment
AT troostdirk steroidresponsiveencephalopathyincerebralamyloidangiopathyacasereportandreviewofevidenceforimmunosuppressivetreatment
AT eikelenboompiet steroidresponsiveencephalopathyincerebralamyloidangiopathyacasereportandreviewofevidenceforimmunosuppressivetreatment
AT nederkoornpaulj steroidresponsiveencephalopathyincerebralamyloidangiopathyacasereportandreviewofevidenceforimmunosuppressivetreatment